CPAP for secondary cardiovascular prevention in obstructive sleep apnoea patients: not only one moon, but many stars
While continuous positive airway pressure (CPAP) therapy has a strong evidence base for the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity remains unclear. This journal club reviews three recent randomised controlled trials aimed to evaluate the impact of CPAP...
Main Authors: | Sébastien Baillieul, Neeraj M. Shah, Rivindi Dharmasena, Sophia Schiza, Dries Testelmans, Athanasia Pataka |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2022-09-01
|
Series: | Breathe |
Online Access: | http://breathe.ersjournals.com/content/18/3/220148.full |
Similar Items
-
Overlaps between obstructive sleep apnoea and other respiratory diseases, including COPD, asthma and interstitial lung disease
by: Izolde Bouloukaki, et al.
Published: (2022-09-01) -
Non-CPAP therapy for obstructive sleep apnoea
by: Johan Verbraecken, et al.
Published: (2022-09-01) -
Screening for obstructive sleep apnoea in professional drivers
by: Sophia E. Schiza, et al.
Published: (2020-03-01) -
From CPAP to tailored therapy for obstructive sleep Apnoea
by: Kate Sutherland, et al.
Published: (2018-12-01) -
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea
by: Winfried Randerath, et al.
Published: (2021-12-01)